Navigation Links
InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
Date:2/5/2010

FT. LAUDERDALE, Fla., Feb. 5 /PRNewswire-FirstCall/ -- InfoSpi Inc. (OTC Bulletin Board: ISPI) announced today an important development within the process of the negotiations to acquire the business and advanced technology of Integral Bioenergies Systems, SL (IBS). This firm has developed and protected a proprietary technology process that allows the treatment of biomass/sludge obtained at sewage treatment plants.

IBS has entered into a contract with Tedagua (www.tedagua.com), a member of the ACS Group (www.acscorporate.com). Tedagua is a worldwide leader in the industry of water treatment plants operating projects in many cities of Mexico, Central and South America, Africa, China and the Middle East.

Onildo Mersing Huusmann, President and CEO of IBS, said, "This contract will allow the future use of IBS's technology in the processing and treatment of biomass/sludge obtained at sewage/water-treatment plants."

Chris Hamilton, CEO of InfoSpi states that this contract shall afford a great opportunity for InfoSpi in the development of its plans.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of InfoSpi Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

www.infospiinc.com

SOURCE InfoSpi Inc.

RELATED LINKS
http://www.infospiinc.com

'/>"/>

SOURCE InfoSpi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market
2. Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
5. Adaptive Trial Paper Explores Benefits of Adaptive Trials for Phase I, Phase II Studies
6. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
7. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
8. Commercial Insurance Buyers Benefit From Ample Capacity
9. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
10. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
11. LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017  Market Research Future published a half-cooked research report ... to grow at a CAGR of 12% during the period 2016 ... ... the abnormal cell division without any control. These abnormal cells have ... These cancer cells can spread to other parts of the body ...
(Date:1/17/2017)... , Jan. 17, 2017 The ... at a CAGR of around 7.5% over the ... 2025. Some of the prominent trends that the ... incidences of diseases & graft transplant surgeries and ... Material the market is categorized into immunomodulatory biomaterials, ...
(Date:1/17/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... and earnings conference call will be broadcast live over ... a.m. Eastern Time.  A news release detailing the quarterly ... a.m. Eastern Time the morning of the conference call. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:1/17/2017)... , Jan. 17, 2017 Research and ... "Molecular Diagnostics - Technologies, Markets and Companies" to ... ... has increased remarkably during the past few years. More than ... molecular diagnostics and 342 of these are profiled in the ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced ... "Digital Life Alliance" established by iCarbonX, the ... to build a "Global Digital Health Ecosystem that ... a combination of individual,s biological, behavioral and psychological ... agreement between the companies, SomaLogic will provide proteomics ...
(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
Breaking Biology News(10 mins):